Published in PLoS Pathog on November 01, 2007
Circulating virus load determines the size of bottlenecks in viral populations progressing within a host. PLoS Pathog (2012) 1.11
Herpesvirus BACs: past, present, and future. J Biomed Biotechnol (2010) 1.08
Identification and characterization of equine herpesvirus type 1 pUL56 and its role in virus-induced downregulation of major histocompatibility complex class I. J Virol (2012) 0.93
Major histocompatibility complex class I downregulation induced by equine herpesvirus type 1 pUL56 is through dynamin-dependent endocytosis. J Virol (2014) 0.92
Equine Herpesvirus 1 Multiply Inserted Transmembrane Protein pUL43 Cooperates with pUL56 in Downregulation of Cell Surface Major Histocompatibility Complex Class I. J Virol (2015) 0.87
Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant. Vet Res (2011) 0.86
Tracking viral evolution during a disease outbreak: the rapid and complete selective sweep of a circovirus in the endangered Echo parakeet. J Virol (2012) 0.86
Clinical observations and management of a severe equine herpesvirus type 1 outbreak with abortion and encephalomyelitis. Acta Vet Scand (2013) 0.85
Isolation and characterization of bovine herpesvirus 4 (BoHV-4) from a cow affected by post partum metritis and cloning of the genome as a bacterial artificial chromosome. Reprod Biol Endocrinol (2009) 0.84
Effective treatment of respiratory alphaherpesvirus infection using RNA interference. PLoS One (2009) 0.82
Replication characteristics of equine herpesvirus 1 and equine herpesvirus 3: comparative analysis using ex vivo tissue cultures. Vet Res (2016) 0.80
Felid herpesvirus 1 as a causative agent of severe nonsuppurative meningoencephalitis in a domestic cat. J Clin Microbiol (2012) 0.79
Comparative analysis of glycoprotein B (gB) of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in cellular tropism and cell-to-cell transmission. Viruses (2015) 0.78
Equine herpesvirus type 1 infection induces procoagulant activity in equine monocytes. Vet Res (2013) 0.78
Equine herpesvirus-1, non-neurogenic pathotype, in a 9-year-old American Saddlebred with neurological signs. Can Vet J (2009) 0.77
Experimental infection with equine herpesvirus type 1 (EHV-1) induces chorioretinal lesions. Vet Res (2013) 0.77
Role of gB and pUS3 in Equine Herpesvirus 1 Transfer between Peripheral Blood Mononuclear Cells and Endothelial Cells: a Dynamic In Vitro Model. J Virol (2015) 0.76
New real-time PCR assay using allelic discrimination for detection and differentiation of equine herpesvirus-1 strains with A2254 and G2254 polymorphisms. J Clin Microbiol (2012) 0.75
Zebra Alphaherpesviruses (EHV-1 and EHV-9): Genetic Diversity, Latency and Co-Infections. Viruses (2016) 0.75
Long term stability and infectivity of herpesviruses in water. Sci Rep (2017) 0.75
Pharmacokinetics of ganciclovir and valganciclovir in the adult horse. J Vet Pharmacol Ther (2013) 0.75
The Role of the Equine Herpesvirus Type 1 (EHV-1) US3-Encoded Protein Kinase in Actin Reorganization and Nuclear Egress. Viruses (2016) 0.75
Detection of the neuropathogenic variant of equine herpesvirus 1 associated with abortions in mares in Poland. BMC Vet Res (2015) 0.75
A Point Mutation in a Herpesvirus Co-Determines Neuropathogenicity and Viral Shedding. Viruses (2017) 0.75
Genetic characterization of equid herpesvirus type 1 from cases of abortion in Poland. Arch Virol (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res (2003) 25.86
A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics (2001) 15.03
An attempt to unify the structure of polymerases. Protein Eng (1990) 7.93
Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques (2006) 5.91
Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci U S A (1997) 5.37
Structure of the replicating complex of a pol alpha family DNA polymerase. Cell (2001) 5.26
Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition. Proc Natl Acad Sci U S A (1988) 2.27
Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Prog Vet Microbiol Immunol (1986) 2.10
Crystal structure of the herpes simplex virus 1 DNA polymerase. J Biol Chem (2006) 1.98
Forward with BACs: new tools for herpesvirus genomics. Trends Genet (2000) 1.66
Mutations in the herpes simplex virus DNA polymerase gene conferring hypersensitivity to aphidicolin. Nucleic Acids Res (1983) 1.56
Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J Virol (2004) 1.38
Inhibition of herpes simplex virus-induced DNA polymerase, cellular DNA polymerase alpha, and virus production by aphidicolin. Biochim Biophys Acta (1980) 1.27
Getting a grip on how DNA polymerases function. Nat Struct Biol (2001) 1.25
Distribution of equid herpesvirus-1 (EHV-1) in respiratory tract associated lymphoid tissue: implications for cellular immunity. Equine Vet J (1994) 1.23
Spinal cord disease in the horse. Cornell Vet (1978) 1.09
Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: equine stroke. Arch Virol (1986) 1.08
The alpha-TIF (VP16) homologue (ETIF) of equine herpesvirus 1 is essential for secondary envelopment and virus egress. J Virol (2006) 1.02
Equine cerebrospinal fluid: reference values of normal horses. Am J Vet Res (1977) 1.01
Equine herpesvirus 1 myeloencephalopathy. Vet Clin North Am Equine Pract (1997) 0.97
The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. J Gen Virol (1990) 0.97
Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1). Vaccine (2006) 0.95
Equine herpesvirus type 1 (EHV-1) myeloencephalopathy: a case report. J Vet Med B Infect Dis Vet Public Health (2002) 0.95
An outbreak of paresis in mares and geldings associated with equid herpesvirus 1. Vet Rec (1981) 0.91
Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1. Equine Vet J (2006) 0.89
Differential susceptibility of equine and mouse brain microvascular endothelial cells to equine herpesvirus 1 infection. Arch Virol (2005) 0.86
Detection of Marek's disease virus DNA in chicken but not in human plasma. J Clin Microbiol (2003) 0.85
Immunohistochemical demonstration of equine herpesvirus-1 antigen in neurons and astrocytes of horses with acute paralysis. Vet Pathol (1997) 0.84
[Establishment and use of infectious bacterial artificial chromosome (BAC) DNA clones of animal herpesviruses]. Berl Munch Tierarztl Wochenschr (2003) 0.82
Comparison of the pathogenesis of acute equine herpesvirus 1 (EHV-1) infection in the horse and the mouse model: a review. Vet Microbiol (1999) 0.81
Cloning, expression, and functional characterization of the equine herpesvirus 1 DNA polymerase and its accessory subunit. J Virol (2006) 0.81
Characterization of the beta2-microglobulin gene of the horse. Immunogenetics (2002) 0.79
Bat white-nose syndrome: an emerging fungal pathogen? Science (2008) 6.32
Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques (2006) 5.91
Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol (2006) 3.59
Histopathologic criteria to confirm white-nose syndrome in bats. J Vet Diagn Invest (2009) 2.98
En passant mutagenesis: a two step markerless red recombination system. Methods Mol Biol (2010) 2.90
Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol (2005) 2.45
Global analysis of the Mycobacterium tuberculosis Zur (FurB) regulon. J Bacteriol (2006) 2.33
Excretion of West Nile virus in urine during acute infection. J Infect Dis (2013) 1.95
Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system. Gastroenterology (2013) 1.83
A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C. Hepatology (2009) 1.78
A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9. J Virol (2007) 1.76
Transmission of equine influenza virus to English foxhounds. Emerg Infect Dis (2008) 1.72
Applications of next-generation sequencing technologies to diagnostic virology. Int J Mol Sci (2011) 1.64
Characterization of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth. J Virol (2002) 1.63
Characterization of a Mycobacterium tuberculosis ESX-3 conditional mutant: essentiality and rescue by iron and zinc. J Bacteriol (2009) 1.62
Diagnostic utility of human cytomegalovirus-specific T-cell response monitoring in predicting viremia in pediatric allogeneic stem-cell transplant patients. Transplantation (2012) 1.59
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. Proc Natl Acad Sci U S A (2007) 1.56
WU and KI polyomaviruses in the brains of HIV-positive patients with and without progressive multifocal leukoencephalopathy. J Infect Dis (2009) 1.55
Human papillomavirus sperm infection and assisted reproduction: a dangerous hazard with a possible safe solution. Hum Reprod (2012) 1.54
Global transcriptional response to vancomycin in Mycobacterium tuberculosis. Microbiology (2009) 1.46
The cytomegalovirus DNA polymerase subunit UL44 forms a C clamp-shaped dimer. Mol Cell (2004) 1.44
Expression of aromatase and estrogen receptors in human adrenocortical tumors. Virchows Arch (2007) 1.44
Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proc Natl Acad Sci U S A (2010) 1.43
Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis. J Antimicrob Chemother (2009) 1.43
Isolation of infectious Zika virus from saliva and prolonged viral RNA shedding in a traveller returning from the Dominican Republic to Italy, January 2016. Euro Surveill (2016) 1.41
Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J Virol (2004) 1.38
The protein encoded by the US3 orthologue of Marek's disease virus is required for efficient de-envelopment of perinuclear virions and involved in actin stress fiber breakdown. J Virol (2005) 1.35
PE is a functional domain responsible for protein translocation and localization on mycobacterial cell wall. Mol Microbiol (2007) 1.34
Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol (2005) 1.33
Intracellular trafficking and maturation of herpes simplex virus type 1 gB and virus egress require functional biogenesis of multivesicular bodies. J Virol (2007) 1.33
Intrahost evolutionary dynamics of canine influenza virus in naive and partially immune dogs. J Virol (2010) 1.28
Next-generation sequencing technologies in diagnostic virology. J Clin Virol (2013) 1.28
Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC. J Virol (2007) 1.27
A herpesvirus ubiquitin-specific protease is critical for efficient T cell lymphoma formation. Proc Natl Acad Sci U S A (2007) 1.23
Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men. BMC Infect Dis (2011) 1.23
Protein-protein interactions as targets for antiviral chemotherapy. Rev Med Virol (2002) 1.21
The equine herpesvirus 1 UL34 gene product is involved in an early step in virus egress and can be efficiently replaced by a UL34-GFP fusion protein. Virology (2002) 1.21
Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control. J Immunol (2006) 1.20
Antimicrobial treatment and containment measures for an extremely drug-resistant Klebsiella pneumoniae ST101 isolate carrying pKPN101-IT, a novel fully sequenced bla(KPC-2) plasmid. J Clin Microbiol (2012) 1.19
Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a. J Virol (2005) 1.18
Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation. Am J Physiol Gastrointest Liver Physiol (2005) 1.16
Crystal structure of the cytomegalovirus DNA polymerase subunit UL44 in complex with the C terminus from the catalytic subunit. Differences in structure and function relative to unliganded UL44. J Biol Chem (2005) 1.16
Posttranslational regulation of Mycobacterium tuberculosis extracytoplasmic-function sigma factor sigma L and roles in virulence and in global regulation of gene expression. Infect Immun (2006) 1.15
KPC-mediated resistance in Klebsiella pneumoniae in two hospitals in Padua, Italy, June 2009-December 2011: massive spreading of a KPC-3-encoding plasmid and involvement of non-intensive care units. Gut Pathog (2012) 1.14
Evidence of complex transcriptional, translational, and posttranslational regulation of the extracytoplasmic function sigma factor sigmaE in Mycobacterium tuberculosis. J Bacteriol (2008) 1.13
Development of a repressible mycobacterial promoter system based on two transcriptional repressors. Nucleic Acids Res (2010) 1.13
Disruption of protein-protein interactions: towards new targets for chemotherapy. J Cell Physiol (2005) 1.13
Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma. J Hepatol (2005) 1.13
A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis. J Exp Med (2006) 1.12
Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines. J Virol (2003) 1.12
Recovery of little brown bats (Myotis lucifugus) from natural infection with Geomyces destructans, white-nose syndrome. J Wildl Dis (2011) 1.12
T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am J Gastroenterol (2008) 1.12
Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results. Cancer Gene Ther (2005) 1.11
Lactobacillus crispatus M247-derived H2O2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-gamma in the intestinal mucosa. Gastroenterology (2008) 1.10
Analysis of the association of the human cytomegalovirus DNA polymerase subunit UL44 with the viral DNA replication factor UL84. J Virol (2009) 1.09
Clinical and prognostic significance of human papillomavirus DNA in the sperm or exfoliated cells of infertile patients and subjects with risk factors. Fertil Steril (2010) 1.09
Equine herpesvirus type 1 devoid of gM and gp2 is severely impaired in virus egress but not direct cell-to-cell spread. Virology (2002) 1.09
Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred. Langenbecks Arch Surg (2009) 1.08
Aggregating phenotype in Lactobacillus crispatus determines intestinal colonization and TLR2 and TLR4 modulation in murine colonic mucosa. Clin Vaccine Immunol (2007) 1.08
Varicellovirus UL 49.5 proteins differentially affect the function of the transporter associated with antigen processing, TAP. PLoS Pathog (2008) 1.08
Synthesis and biological activity of 7-phenyl-6,9-dihydro-3H-pyrrolo[3,2-f]quinolin-9-ones: a new class of antimitotic agents devoid of aromatase activity. J Med Chem (2006) 1.07
The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J Gen Virol (2002) 1.07
Distribution of human papillomavirus types in the anogenital tract of females and males. J Med Virol (2010) 1.07
Antiviral strategies against influenza virus: towards new therapeutic approaches. Cell Mol Life Sci (2014) 1.07
Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection. J Med Virol (2004) 1.06
Herpesvirus telomeric repeats facilitate genomic integration into host telomeres and mobilization of viral DNA during reactivation. J Exp Med (2011) 1.06
Human papillomavirus found in sperm head of young adult males affects the progressive motility. Fertil Steril (2008) 1.05
The gene 10 (UL49.5) product of equine herpesvirus 1 is necessary and sufficient for functional processing of glycoprotein M. J Virol (2002) 1.05
Human papillomavirus genotyping by 454 next generation sequencing technology. J Clin Virol (2011) 1.04
Ultrarapid detection of blaKPC₁/₂-₁₂ from perirectal and nasal swabs by use of real-time PCR. J Clin Microbiol (2012) 1.04
Characterisation of qnr plasmid-mediated quinolone resistance in Enterobacteriaceae from Italy: association of the qnrB19 allele with the integron element ISCR1 in Escherichia coli. Int J Antimicrob Agents (2010) 1.04
Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses. Antiviral Res (2006) 1.03
vLIP, a viral lipase homologue, is a virulence factor of Marek's disease virus. J Virol (2005) 1.03
Marek's disease virus: lytic replication, oncogenesis and control. Expert Rev Vaccines (2006) 1.03
The alpha-TIF (VP16) homologue (ETIF) of equine herpesvirus 1 is essential for secondary envelopment and virus egress. J Virol (2006) 1.02
Complete genome sequence of virulent duck enteritis virus (DEV) strain 2085 and comparison with genome sequences of virulent and attenuated DEV strains. Virus Res (2011) 1.01
Comparative evaluation of three computerized algorithms for prediction of antiretroviral susceptibility from HIV type 1 genotype. J Antimicrob Chemother (2003) 1.00
Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase. Proc Natl Acad Sci U S A (2012) 1.00
Generation of a permanent cell line that supports efficient growth of Marek's disease virus (MDV) by constitutive expression of MDV glycoprotein E. J Gen Virol (2002) 1.00
Esophageal achalasia: is the herpes simplex virus really innocent? J Gastrointest Surg (2004) 0.99
A novel streptococcal integrative conjugative element involved in iron acquisition. Mol Microbiol (2008) 0.99
Equine herpesvirus 1 entry via endocytosis is facilitated by alphaV integrins and an RSD motif in glycoprotein D. J Virol (2008) 0.99
Human endogenous retroviruses and cancer prevention: evidence and prospects. BMC Cancer (2013) 0.99
Binding parameters and thermodynamics of the interaction of the human cytomegalovirus DNA polymerase accessory protein, UL44, with DNA: implications for the processivity mechanism. Nucleic Acids Res (2007) 0.99
Baseline cellular HIV DNA load predicts HIV DNA decline and residual HIV plasma levels during effective antiretroviral therapy. J Clin Microbiol (2011) 0.98
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones. J Med Chem (2005) 0.98
Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)--masters of co-evolution and a constant threat to equids and beyond. Vet Microbiol (2013) 0.97
The ESX-3 secretion system is necessary for iron and zinc homeostasis in Mycobacterium tuberculosis. PLoS One (2013) 0.97
Varicella-zoster virus open reading frame 66 protein kinase is required for efficient viral growth in primary human corneal stromal fibroblast cells. J Virol (2008) 0.97
Contribution of gene products encoded within the unique short segment of equine herpesvirus 1 to virulence in a murine model. Virus Res (2002) 0.97
Functional analysis of the murine cytomegalovirus chemokine receptor homologue M33: ablation of constitutive signaling is associated with an attenuated phenotype in vivo. J Virol (2007) 0.97
110 years of Avipoxvirus in the Galapagos Islands. PLoS One (2011) 0.97
Infection dynamics in a traveller with persistent shedding of Zika virus RNA in semen for six months after returning from Haiti to Italy, January 2016. Euro Surveill (2016) 0.96